Dr. Reddy's Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 24, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Cap	9,970	11,533	11,006	12,240	9,463	9,252
Market Cap Growth	-18.17%	4.78%	-10.08%	29.35%	2.27%	-8.76%
Enterprise Value	9,906	11,629	10,920	11,745	8,875	9,114
Last Close Price	11.79	13.85	13.19	14.68	11.39	11.15
PE Ratio	28.47	25.72	16.63	18.31	17.28	29.87
PS Ratio	2.85	-	2.89	3.66	3.16	3.28
PB Ratio	2.44	2.85	2.80	3.61	3.34	3.66
P/TBV Ratio	0.05	0.05	0.05	0.05	0.05	0.06
P/FCF Ratio	45.10	32.25	49.71	35.15	16.35	52.23
P/OCF Ratio	22.88	19.00	20.26	22.46	13.21	24.99
EV/Sales Ratio	2.83	-	2.87	3.51	2.97	3.23
EV/EBITDA Ratio	36.30	-	10.50	11.86	10.45	16.75
EV/EBIT Ratio	186.90	-	12.99	14.46	12.76	23.47
EV/FCF Ratio	44.81	32.52	49.32	33.73	15.34	51.44
Debt / Equity Ratio	0.18	0.20	0.14	0.07	0.05	0.17
Debt / EBITDA Ratio	2.74	-	0.53	0.24	0.19	0.82
Debt / FCF Ratio	6.53	2.31	2.47	0.69	0.28	2.52
Net Debt / Equity Ratio	-0.02	0.02	-0.03	-0.15	-0.21	-0.05
Net Debt / EBITDA Ratio	-0.36	-0.02	-0.12	-0.50	-0.69	-0.25
Net Debt / FCF Ratio	-0.86	0.17	-0.59	-1.42	-1.02	-0.78
Asset Turnover	0.27	0	0.74	0.78	0.79	0.76
Inventory Turnover	1.06	1.66	2.01	2.06	2.14	1.86
Quick Ratio	1.16	1.03	1.14	1.48	1.57	1.14
Current Ratio	1.90	1.80	1.92	2.59	2.38	1.82
Return on Equity (ROE)	8.37%	11.52%	18.41%	21.61%	21.21%	12.91%
Return on Assets (ROA)	0.87%	-54.50%	12.13%	14.75%	13.75%	7.64%
Return on Invested Capital (ROIC)	1.30%	-81.85%	18.81%	24.65%	23.30%	12.26%
Return on Capital Employed (ROCE)	1.24%	-75.37%	21.88%	25.56%	26.16%	15.44%
Earnings Yield	3.51%	3.89%	6.01%	5.46%	5.79%	3.35%
FCF Yield	2.22%	3.10%	2.01%	2.84%	6.11%	1.91%
Dividend Yield	0.55%	0.62%	0.71%	0.65%	0.64%	0.59%
Payout Ratio	15.30%	15.87%	11.78%	11.94%	11.05%	17.59%
Buyback Yield / Dilution	0.05%	0.10%	-0.08%	-0.19%	-0.03%	-0.01%
Total Shareholder Return	0.60%	0.72%	0.63%	0.46%	0.61%	0.58%

SEC Filings: 10-K · 10-Q